Market revenue in 2023 | USD 42.4 million |
Market revenue in 2030 | USD 67.7 million |
Growth rate | 6.9% (CAGR from 2023 to 2030) |
Largest segment | Product registration & clinical trial applications |
Fastest growing segment | Legal representation |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Regulatory consulting, Legal representation, Regulatory writing & publishing, Product registration & clinical trial applications, Regulatory Submissions, Regulatory Operations, Other services |
Key market players worldwide | Genpact Ltd, Criterium Inc., Promedica International, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Icon PLC, Labcorp Drug Development, FREYR Battery Inc, Cencora Inc, Pharmexon, QVigilance, BlueReg Group, ZEINCRO Group |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to regulatory affairs outsourcing market will help companies and investors design strategic landscapes.
Product registration & clinical trial applications was the largest segment with a revenue share of 25.94% in 2023. Horizon Databook has segmented the Switzerland regulatory affairs outsourcing market based on regulatory consulting, legal representation, regulatory writing & publishing, product registration & clinical trial applications, regulatory submissions, regulatory operations, other services covering the revenue growth of each sub-segment from 2018 to 2030.
The combination of well-developed healthcare infrastructure and R&D facilities makes Switzerland one of the most important lucrative markets globally. The country is one of the major manufacturing hubs in Europe with 90.0% export production.
In addition, the country is one of the innovative biotechnology hubs with the pharmaceutical & biotechnology sector accounting for nearly 40% of the country’s exports.
The production cost is relatively low as compared to countries such as UK & Germany and most of the manufacturing in the country is done through contract manufacturers, thereby facilitating the demand for services such as legal representation, regulatory strategies & intelligence, and regulatory liaising services.
Horizon Databook provides a detailed overview of country-level data and insights on the Switzerland regulatory affairs outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Switzerland regulatory affairs outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account